Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Fierce Biotech4d
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Google’s DeepMind Tightens AI Research Release amid AI Competition
AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...
AI startup SandboxAQ adds Nvidia, Google as backers, raises additional $150 million
SandboxAQ, a startup drawing on quantum computing techniques to develop quantitative artificial intelligence models for ...
Google DeepMind’s drug discovery spin-off Isomorphic Labs raises $600mn
Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...
Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
It was joined by Alphabet and GV, the search giant’s startup investment arm. Isomorphic Labs is led by Chief Executive ...